Keyword: United Kingdom

After a previous rejection and a discount offer, Roche's immunotherapy Tecentriq snagged an OK from England's influential cost-effectiveness watchdogs.

The cost-effectiveness gatekeeper figures Dupixent works—and offers an option for patients who really need one—but isn't sure it's worth the price.

Pfizer is training pharmacists in the U.K. to handle over-the-counter Viagra.

NICE’s loss is the pharma industry’s gain in the U.K. as Carole Longson, a respected authority in drug value assessment, has joined ABPI.

Viagra Connect, the Pfizer OTC name for its blockbuster erectile dysfunction drug, has been approved for sale in the U.K.

With all eyes fixed on Monday's vote for the European Medicines Agency relocation, Milan and Amsterdam emerged as top picks.

With time running short, EU members have been asked to set aside parochial interests in their pick for a new city to host the EMA.

Pharmaceutical companies took a hard stance against new cost-management strategies in England but have now fallen short.

As the EMA prepares to move, officials have unveiled the list of cities staffers say would keep them around.

Researchers in England are kicking off the world's first large human trial of a "universal" influenza shot.